Gaticept represents a sterile ophthalmic solution carefully formulated with Gatifloxacin 0.3% w/v and Benzalkonium Chloride IP 0.02% v/v as a preservative. This advanced formulatio...

Gaticept represents a sterile ophthalmic solution carefully formulated with Gatifloxacin 0.3% w/v and Benzalkonium Chloride IP 0.02% v/v as a preservative. This advanced formulation delivers effective treatment for bacterial eye infections through broad-spectrum antibacterial action against common pathogens. The solution is prepared in an aqueous base that ensures optimal compatibility with ocular tissues while minimizing potential irritation. Manufactured under stringent quality controls, every batch guarantees sterility, potency, and safety for end-users. Rigorous testing ensures compliance with pharmacopeial standards, establishing this product as a trusted choice among medical professionals. The practical dropper bottle packaging facilitates easy and hygienic application, complemented by clear labeling for proper dosage instructions and storage guidelines.

This ophthalmic solution finds extensive application across hospitals, specialized eye clinics, and various healthcare institutions for managing conditions such as bacterial conjunctivitis, keratitis, and corneal ulcers. Pharmacies regularly stock this product for retail distribution, effectively catering to outpatient treatment needs. Multiple sectors including healthcare, pharmaceuticals, and veterinary medicine depend on Gaticept for its proven efficacy and consistent reliability. The product proves particularly valuable in clinical settings requiring rapid infection control, including surgical units and emergency care departments. Ophthalmologists, physicians, and veterinarians consistently choose this solution for delivering effective treatment outcomes across diverse patient populations.

Gaticept delivers substantial business value through its demonstrated reliability, consistent quality standards, and strong market acceptance. Distributors and wholesalers benefit from offering a competitively priced, high-demand product that meets evolving market needs. The solution distinguishes itself through strict adherence to IP standards, ensuring regulatory compliance and building user trust throughout the supply chain. Its extended shelf life and robust packaging design minimize storage concerns and reduce transportation risks. Businesses incorporating Gaticept into their portfolio gain access to a reputable product that efficiently addresses diverse customer requirements while enhancing their professional standing in the healthcare marketplace.

Key Features:
- Contains Gatifloxacin 0.3% w/v for comprehensive antibacterial coverage
- Includes Benzalkonium Chloride IP 0.02% v/v as an effective preservative
- Sterile aqueous base formulation ensures patient safety and comfort
- Manufactured under strict quality control meeting IP standards
- User-friendly dropper bottles enable precise dosage administration

Benefits:
- Rapid relief from bacterial eye infections through potent antibacterial action
- Enhanced product stability and shelf life through effective preservation
- Minimal ocular irritation due to biocompatible aqueous formulation
- Consistent quality assurance through rigorous manufacturing standards
- Convenient and accurate application with practical dropper packaging